MAPT and Alzheimer disease: Phosphorylated form of the protein Tau (Bejanin et al. 2017), a pathologically relevant agent in AD, was recently found to interact with nuclear pore components and disrupt nuclear protein transport leading to cytosolic protein mislocalization, which in turn facilitated cytosolic Tau aggregate formation (Eftekharzadeh et al. 2018).